期刊文献+

血栓分子标志物对下肢深静脉血栓形成的诊断及抗凝疗效的评价 被引量:27

A evaluation of coagulation biomarkers for diagnosis and therapeutic monitoring of deep venous thrombosis of lower extremities
下载PDF
导出
摘要 目的观察下肢深静脉血栓患者血栓分子标志物的变化,分析其对静脉血栓形成诊断及疗效评估的价值。方法选取2018年12月至2019年5月北京积水潭医院创伤骨科下肢骨折术后深静脉血栓形成(DVT)患者64例为DVT组,未诊断为DVT患者39例为非DVT组;同期体检健康者28例为健康人对照组。采集静脉血并检测初诊时及利伐沙班抗凝治疗1个月后血栓分子标志物,即凝血酶-抗凝血酶复合物(TAT)、纤溶酶-α2纤溶酶抑制剂复合物(PIC)、组织型纤溶酶原激活物-纤溶酶原激活物抑制剂复合物(t-PAIC)及可溶性血栓调节蛋白(sTM),并进行统计学分析。结果DVT组血浆TAT、PIC、t-PAIC、sTM水平均高于非DVT组(P均<0.05),DVT组血浆TAT、PIC、t-PAIC水平均高于健康人对照组(P均<0.05),DVT组血浆sTM水平与健康人对照组差异无统计学意义(P>0.05)。TAT、PIC、t-PAIC诊断DVT的ROC曲线下面积分别为0.997、0.980、0.758,约登指数最大时取cut-off值,cut-off值分别为2.45 ng/mL、0.715μg/mL、0.758 ng/mL;根据测定值>cut-off值为阳性,测定值<cut-off值为阴性,抗凝治疗1个月前后患者组TAT、PIC、t-PAIC水平及阳性率差异均有统计学意义(P均<0.05)。结论血栓分子标志物TAT、PIC、t-PAIC能有效发现下肢DVT,同时对评估DVT患者抗凝疗效有意义。 Objective To evaluate the changes of molecular markers of thrombosis in patients with deep venous thrombosis of lower extremities and analyze their value in the detection of venous thrombosis and evaluate the therapeutic effects.Methods In case-control study,we selected traumatic patients after surgery from Beijing Jishuitan Hospital during December 2018 to May 2019.A total of 64 patients with thrombosis were in DVT group,39 patients without thrombosis were in non-DVT group,and 28 healthy subjects in the same period were in healthy control group.Venous blood samples were taken from all these people.Coagulation parameters thrombin-antithrombin complexes(TAT),plasmin-α2-plasmin inhibitor complexes(PIC)and tissue-type plasminogen activator-inhibitor complexes(t-PAIC)were detected at first diagnosis and one month after rivaroxaban anticoagulation therapy beginning.The differences of the markers between these groups were compared.Results The coagulation markers of the patients with lower extremity deep venous thrombosis increased significantly at diagnosis.The levels of plasma TAT,PIC,t-PAIC and sTM in DVT group were significantly high-er than those in non-DVT group(P<0.05).The levels of plasma TAT,PIC and t-PAIC in DVT group were higher than those in healthy control group(P<0.05).There was no significant difference in sTM level between DVT group and healthy control group(P>0.05).The results and changes of TAT,PIC,t-PAIC in the patients before and after one month of anticoagulation therapy were statistically different(P<0.05)in comparison.Conclusion The molecular markers of thrombosis,TAT,PIC and t-PAIC,could effectively detect deep venous thrombosis of lower extremities and showed significant efficacy in evaluating the efficacy of anticoagulation therapy.
作者 文梦 赵慧茹 赵育婧 曹辉 陈玉莹 章文洁 曹翔宇 吴俊 WEN Meng;ZHAO Huiru;ZHAO Yujing;CAO hui;CHEN Yuying;ZHANG Wenjie;CAO Xiangyu;WU Jun(Department of Laboratory Medicine,Beijing Jishuitan Hospital,Beijing 100035;The 4th Affiliated Hospital of Peking University,Beijing 100035,China)
出处 《临床检验杂志》 CAS 2019年第9期671-674,共4页 Chinese Journal of Clinical Laboratory Science
基金 北京市卫生系统第五批215高层次人才培养计划(编号:2015-3-034) 人社部留学人员科技活动项目([2015]192)
关键词 下肢深静脉血栓 凝血酶-抗凝血酶复合物 纤溶酶-α2抗纤溶酶抑制剂复合物 组织型纤溶酶原激活物-纤溶酶原激活物抑制剂复合物 血栓调节蛋白 疗效监测 deep vein thrombosis thrombin-antithrombin complexes plasmin-α2-plasmin inhibitor complexes tissue-type plasminogen activator-inhibitor complexes thrombomodulin efficacy monitor
  • 相关文献

参考文献4

二级参考文献31

  • 1Whiting PS, Jahangir AA. Thromboembolic Disease After Orthopedic Trauma[J]. Orthop Clin North Am, 2016,47 (2): 335-344.
  • 2Wu PK, Chen CF, Chung LH, et al. Population-based epidemiology of postoperative venous thromboembolism in Taiwan Residents patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis[ J]. Thromb Res, 2014,133 (5) :719-724.
  • 3Wood RC, Stewart DW, Slusher L, et al. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data [ J ]. Pharmacotherapy, 2015,35 ( 7 ) : 663-669.
  • 4Granziera S, Cohen AT. VTE primary prevention, including hospitalised medical and orthopaedic surgical patients [ J ]. Thromb Haemost, 2015,113 (6) : 1216-1223.
  • 5Dahl OE, Harenberg J, Wexels F, et al. Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for intervention [ J ]. Semin Thromb Hemost, 2015,41 (2) :141-145.
  • 6Su EP, Chatzoudis N, Sioros V, et al. Markers of thrombin generation during resurfaeing and noncemented total hip arthroplasty: a pilot study[ J]. Clin Orthop Relat Res, 2011,469 (2) :535-540.
  • 7Hughes SF, Hendricks BD, Edwards DR, et al. Total hip and knee replacement surgery results in changes in leukocyte and endothelial markers [ J ]. J Inflamm ( Lond), 2010,7 : 2.
  • 8Fedi S, Gori AM, Falciani M, et al. Procedure-dependence and tissue factor-independence of hypercoagulability during orthopaedic surgery[J]. Thromb Haemnst, 1999,81 (6) :874-878.
  • 9Cofrancesco E, Cortellaro M, Corradi A, et al. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery [ J]. Thromb Haemost, 1997,77 ( 2 ) : 267- 269.
  • 10Lazo-Langner A, Fleet JL, McArthur E, et al. Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study [J]. J Thromb Haemost, 2014,12(10) :1626-1635.

共引文献97

同被引文献257

引证文献27

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部